Cargando…
Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation
Glioblastoma multiforme (GBM) is the most common and deadly brain cancer, characterized by its aggressive proliferation to adjacent tissue and high recurrence rate. We studied the efficacy and related mechanisms of the combination of cyclopamine (Cyp, a Sonic-hedgehog pathway (Shh) inhibitor) and te...
Autores principales: | Liu, Yu-Jie, Ma, Ying-Cong, Zhang, Wen-Jie, Yang, Zhen-Zhen, Liang, De-Sheng, Wu, Zhi-Fu, Qi, Xian-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522083/ https://www.ncbi.nlm.nih.gov/pubmed/28477008 http://dx.doi.org/10.18632/oncotarget.17205 |
Ejemplares similares
-
Gli3 silencing enhances cyclopamine suppressive effects on ovarian cancer
por: Liu, Hai-Yan, et al.
Publicado: (2014) -
Combination of Cyclopamine and Tamoxifen Promotes Survival and Migration of MCF-7 Breast Cancer Cells – Interaction of Hedgehog-Gli and Estrogen Receptor Signaling Pathways
por: Sabol, Maja, et al.
Publicado: (2014) -
Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide
por: Melamed, Jilian R., et al.
Publicado: (2018) -
Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
por: Wang, Ke, et al.
Publicado: (2017) -
Tumor shrinkage by cyclopamine tartrate through inhibiting hedgehog signaling
por: Fan, Qipeng, et al.
Publicado: (2011)